Renalytix PLC
LSE:RENX

Watchlist Manager
Renalytix PLC Logo
Renalytix PLC
LSE:RENX
Watchlist
Price: 10.75 GBX 7.93% Market Closed
Market Cap: 35.6m GBX
Have any thoughts about
Renalytix PLC?
Write Note

EV/EBIT
Enterprise Value to EBIT

43.2
Current
42.7
Median
17.1
Industry
Higher than median
Higher than industry value

Enterprise Value to EBIT (EV/EBIT) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s earnings before interest and taxes (EBIT). Considered one of the most frequently used multiples for comparisons among companies, the EV/EBIT multiple relies on operating income as the core driver of valuation.

EV/EBIT
43.2
=
Enterprise Value
-1.5B GBX
/
EBIT
-42.4m USD
All Countries
All Countries
Close
EBIT Growth EV/EBIT to Growth
UK
Renalytix PLC
LSE:RENX
Average EV/EBIT: 472.7
43.2
N/A N/A
US
Veeva Systems Inc
NYSE:VEEV
47.3
239%
0.2
US
C
Cerner Corp
LSE:0R00
43.2
N/A N/A
AU
Pro Medicus Ltd
ASX:PME
220.8
122%
1.8
US
Doximity Inc
NYSE:DOCS
49.9
102%
0.5
US
W
Waystar Holding Corp
NASDAQ:WAY
70.2
N/A N/A
JP
M3 Inc
TSE:2413
13.7
N/A N/A
US
Inspire Medical Systems Inc
NYSE:INSP
383.1
N/A N/A
SE
Sectra AB
STO:SECT B
Negative Multiple: -71.1 N/A N/A
US
V
Vocera Communications Inc
F:V00
3 823.9
N/A N/A
CN
Winning Health Technology Group Co Ltd
SZSE:300253
31.8
123%
0.3

EV/EBIT Forward Multiples

Forward EV/EBIT multiple is a version of the EV/EBIT ratio that uses forecasted EBIT for the EV/EBIT calculation. 1-Year, 2-Years, and 3-Years forwards use EBIT forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBIT
0.7
2-Years Forward
EV/EBIT
1
3-Years Forward
EV/EBIT
1.3

See Also

Summary
RENX intrinsic value, competitors valuation, and company profile.
DCF Valuation
RENX stock valuation using Discount Cash Flow valuation method.
Relative Valuation
RENX stock valuation using valuation multiples.
Wall Street Estimates
RENX price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
RENX stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Follow us
Join more than 210,900+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.